Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 25,248 | 27,745 | 24,747 | 23,912 | 25,533 |
| Cost of Goods | 11,820 | 13,459 | 12,564 | 11,963 | 11,969 |
| Gross Profit | 13,428 | 14,286 | 12,183 | 11,949 | 13,564 |
| Operating Expenses | 26,881 | 23,480 | 28,349 | 29,399 | 32,069 |
| Operating Income | -12,633 | -8,735 | -15,602 | -16,487 | -17,536 |
| Interest Expense | 1,889 | 1,457 | 1,456 | 1,456 | 1,455 |
| Other Income | 92 | -186 | 379 | 183 | 9 |
| Pre-tax Income | -14,430 | -10,378 | -16,679 | -17,760 | -18,982 |
| Income Tax | -1,183 | 78 | -735 | -827 | -1,780 |
| Net Income Continuous | -13,247 | -10,456 | -15,944 | -16,933 | -17,202 |
| Net Income | $-13,247 | $-10,456 | $-15,944 | $-16,933 | $-17,202 |
| EPS Basic Total Ops | -0.34 | -0.21 | -0.46 | -0.58 | -0.59 |
| EPS Basic Continuous Ops | -0.34 | -0.21 | -0.46 | -0.58 | -0.59 |
| EPS Diluted Total Ops | -0.34 | -0.21 | -0.46 | -0.58 | -0.59 |
| EPS Diluted Continuous Ops | -0.34 | -0.21 | -0.46 | -0.58 | -0.59 |
| EBITDA(a) | $-7,345 | $-4,059 | $-11,070 | $-11,550 | $-12,785 |